Literature DB >> 1859938

Immunology of the lung in HIV infection: the pathophysiologic basis for the development of tuberculosis in the AIDS setting.

R M Rose1.   

Abstract

Active tuberculosis is now recognized as a frequent and serious complication of infection with the human immunodeficiency virus (HIV), the causative agent of AIDS. HIV mediated alteration in host defenses against mycobacteria contribute to the magnitude and severity of this problem. HIV can affect a variety of cellular mechanisms important in the restriction of mycobacterial growth. Qualitative and quantitative defects in T lymphocyte function result from direct HIV infection of cells expressing the CD4 epitope, and can severely limit the production of macrophage activating cytokines capable of inducing an anti-mycobacterial state in cells of monocyte lineage. In addition, macrophages themselves are susceptible to HIV infection, and have been shown to be defective with respect to a variety of host defense functions. Both T4 lymphopenia and HIV infected macrophages are present in the lower respiratory tract of HIV infected individuals, a circumstance which likely underlies the unique susceptibility of HIV infected to tuberculosis.

Entities:  

Mesh:

Year:  1991        PMID: 1859938

Source DB:  PubMed          Journal:  Bull Int Union Tuberc Lung Dis        ISSN: 1011-789X


  3 in total

1.  Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990.

Authors:  S E Buskin; J L Gale; N S Weiss; C M Nolan
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

2.  HIV infection and sputum-culture conversion in patients diagnosed with Mycobacterium tuberculosis: a population-based study.

Authors:  Muktar H Aliyu; Hamisu M Salihu; Raoul Ratard
Journal:  Wien Klin Wochenschr       Date:  2003-05-30       Impact factor: 1.704

3.  Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.

Authors:  Catherine Riou; Blas Perez Peixoto; Lindi Roberts; Katharina Ronacher; Gerhard Walzl; Claudia Manca; Roxana Rustomjee; Thuli Mthiyane; Dorothy Fallows; Clive M Gray; Gilla Kaplan
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.